Matsumoto K
Second Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
Nihon Geka Gakkai Zasshi. 1994 Jul;95(7):448-57.
We evaluated killer cell activity and suppressor cell activity as the indicators of immunological function of spleen cells in rats implanted with N-methyl-N'-nitro-N-nitrosoguanidine-induced cancer. The effect of splenectomy on tumor growth was also investigated. Splenectomy was performed 2 (early stage of tumor growth), 5 (intermediate stage), or 8 weeks (late stage) after tumor implantation. The mean survival time of rats splenectomized at the early or intermediate stage of tumor growth was shorter than that of sham-operated rats, while that of rats splenectomized at the late stage was longer than controls. Natural killer (NK) and Cytotoxic T lymphocyte (CTL) activity of spleen lymphocytes of tumor-bearing rats were increased during the intermediate stage of tumor growth and then were declined during the late stage, while suppressor cell activity showed progressive increase after tumor implantation. The results of Winn assay showed that most of the splenic effector cells during the intermediate stage were T-lymphocytes, and some were NK cells. Furthermore suppressor macrophages and suppressor T-lymphocytes were increased in spleen lymphocytes of rats in the late stage of tumor growth. These results suggest that preservation of the spleen may be beneficial in the treatment of gastric cancer at the early and intermediate stage but that splenectomy is necessary for the advanced stage of cancer.
我们评估了杀伤细胞活性和抑制细胞活性,以此作为接种N-甲基-N'-硝基-N-亚硝基胍诱导癌症的大鼠脾细胞免疫功能的指标。还研究了脾切除术对肿瘤生长的影响。在肿瘤接种后2周(肿瘤生长早期)、5周(中期)或8周(晚期)进行脾切除术。在肿瘤生长早期或中期接受脾切除术的大鼠的平均存活时间短于假手术大鼠,而在晚期接受脾切除术的大鼠的平均存活时间长于对照组。荷瘤大鼠脾淋巴细胞的自然杀伤(NK)和细胞毒性T淋巴细胞(CTL)活性在肿瘤生长中期增加,然后在晚期下降,而抑制细胞活性在肿瘤接种后呈进行性增加。Winn试验结果表明,中期大多数脾效应细胞是T淋巴细胞,有些是NK细胞。此外,在肿瘤生长晚期大鼠的脾淋巴细胞中,抑制性巨噬细胞和抑制性T淋巴细胞增加。这些结果表明,保留脾脏可能有利于早期和中期胃癌的治疗,但对于癌症晚期则需要进行脾切除术。